The global demand for Lyme Disease Diagnostics Market is presumed to reach the valuation of nearly USD XX MN by 2026 from USD XX MN in 2019 with a CAGR of XX% under the study period of 2020 - 2026.
Lyme Disease is a bacterial infection transmitted to humans by the bite of an infected tick. The infection is transmitted if the tick stays on the human skin for a period of 36 hours. The symptoms can range from a rash to neurological disorders. The stage of the disease depends on the time taken for the first diagnosis after the tick bite. The various devices used are based on the tests carried out for antibodies like blood, urine, PCR, cardiogram, biopsy, microfluidic, ELISA and western blot.
The increasing number of people infected with the communicable Lyme disease and improving healthcare facilities are the main drivers for the growth of this market. The various initiatives taken by the government in diagnosing the disease at early stages will fuel the growth of this market. The innovative serological test devices will further propel the growth since these are easily accessible and often sought after for initial tests. COVID-19 pandemic will have a positive impact on the market since the symptoms for both Corona and Lyme disease are similar. The main restraining factor for the growth of this market is the lack of awareness of the various devices available for testing Lyme.
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of lyme disease diagnostics.
The entire lyme disease diagnostics market has been sub-categorized into emerging diagnostic technology and end-user. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
By Emerging Diagnostic Technology
By End User
- Serological Test
- Urine Antigen Tests
- Lymphocytic Transformation Test
- Immunofluorescent Staining
- Nucleic Acid Test
- Public/Private Laboratories
- Physicians Office
This section covers regional segmentation which accentuates on current and future demand for lyme disease diagnostics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Europe Lyme Disease Diagnostic Devices Market By Revenue (USD MN)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the lyme disease diagnostics market include Abbott Laboratories, T2 Biosystems, Inc., Bio-Rad Laboratories, Inc., Alere Inc., Roche Diagnostics International Ltd., Graphene Frontiers, LLC, Covance Inc., Immunetics Inc., GlaxoSmithKline Pharmaceuticals Ltd., Boulder Diagnostics Inc., Affymetrix Inc., Siemens AG, Baxter International Inc. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources, Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.